| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |